JANX JANUX THERAPEUTICS INC Offer for Sale 8-K Filing 2024 - Public Offering Janux Therapeutics, Inc. is conducting a public offering of 5,317,460 shares at $63.00 each, aiming for gross proceeds of approximately $350 million, with an option for underwriters to purchase an additional 833,333 shares.Get access to all SEC 8-K filings of the JANUX THERAPEUTICS INC